Financial results that do not meet market expectations typically lead to a negative reaction in the stock market. For Akoya BioSciences, the worse-than-expected Q1 financial performance has directly impacted investor sentiment and share price. The immediate drop in share price reflects the market's reaction to the earnings miss, indicating a short-term negative impact.